BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bloem AEM, Mostard RLM, Stoot N, Vercoulen JH, Peters JB, Janssen DJA, Custers JWH, Spruit MA. Severe Fatigue is Highly Prevalent in Patients with IPF or Sarcoidosis. J Clin Med 2020;9:E1178. [PMID: 32325989 DOI: 10.3390/jcm9041178] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Vaes AW, Goërtz YMJ, van Herck M, Beijers RJHCG, van Beers M, Burtin C, Janssen DJA, Schols AMWJ, Spruit MA. Physical and mental fatigue in people with non-communicable chronic diseases. Annals of Medicine 2022;54:2522-34. [DOI: 10.1080/07853890.2022.2122553] [Reference Citation Analysis]
2 Meregaglia M, Nicod E, Drummond M. The estimation of health state utility values in rare diseases: do the approaches in submissions for NICE technology appraisals reflect the existing literature? A scoping review. Eur J Health Econ 2022. [DOI: 10.1007/s10198-022-01541-y] [Reference Citation Analysis]
3 Kahlmann V, Moor CC, van Helmondt SJ, Mostard RLM, van der Lee ML, Grutters JC, Wijsenbeek MS, Veltkamp M. Online mindfulness-based cognitive therapy for fatigue in patients with sarcoidosis (TIRED): a randomised controlled trial. The Lancet Respiratory Medicine 2022. [DOI: 10.1016/s2213-2600(22)00387-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Sinha S, Castillo V, Espinoza CR, Tindle C, Fonseca AG, Dan JM, Katkar GD, Das S, Sahoo D, Ghosh P. COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis. EBioMedicine 2022;82:104185. [PMID: 35870428 DOI: 10.1016/j.ebiom.2022.104185] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Saketkoo LA, Obi ON, Patterson KC, Russell AM. Ageing with Interstitial lung disease: preserving health and well being. Curr Opin Pulm Med 2022;28:321-36. [PMID: 35749798 DOI: 10.1097/MCP.0000000000000880] [Reference Citation Analysis]
6 Kahlmann V, Patel DC, Marts LT, Wijsenbeek MS. Non-organ-specific manifestations of sarcoidosis. Sarcoidosis 2022. [DOI: 10.1183/2312508x.10032320] [Reference Citation Analysis]
7 Marques A, Souto-miranda S. Respiratory management in daily life. Wearable Sensing and Intelligent Data Analysis for Respiratory Management 2022. [DOI: 10.1016/b978-0-12-823447-1.00010-5] [Reference Citation Analysis]
8 Sinha S, Castillo V, Espinoza CR, Tindle C, Fonseca AG, Dan JM, Katkar GD, Das S, Sahoo D, Ghosh P. COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis.. [DOI: 10.1101/2021.11.28.470269] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Goërtz YMJ, Braamse AMJ, Spruit MA, Janssen DJA, Ebadi Z, Van Herck M, Burtin C, Peters JB, Sprangers MAG, Lamers F, Twisk JWR, Thong MSY, Vercoulen JH, Geerlings SE, Vaes AW, Beijers RJHCG, van Beers M, Schols AMWJ, Rosmalen JGM, Knoop H. Fatigue in patients with chronic disease: results from the population-based Lifelines Cohort Study. Sci Rep 2021;11:20977. [PMID: 34697347 DOI: 10.1038/s41598-021-00337-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
10 Bloem AEM, Mostard RLM, Stoot N, Vercoulen JH, Peters JB, Spruit MA. Perceptions of fatigue in patients with idiopathic pulmonary fibrosis or sarcoidosis. J Thorac Dis 2021;13:4872-84. [PMID: 34527326 DOI: 10.21037/jtd-21-462] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Kushima H, Kinoshita Y, Fujita M, Ishii H. A retrospective study on the efficacy of Ninjin'yoeito on fatigue in patients with interstitial pneumonia. Neuropeptides 2021;89:102178. [PMID: 34298370 DOI: 10.1016/j.npep.2021.102178] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Holland AE, Dowman L, Smallwood N. Patient-reported Outcomes for Clinical Trials in Idiopathic Pulmonary Fibrosis: New Opportunities to Understand How Patients Feel and Function. Am J Respir Crit Care Med 2020;202:1620-2. [PMID: 32749856 DOI: 10.1164/rccm.202007-2775ED] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Cox IA, Borchers Arriagada N, de Graaff B, Corte TJ, Glaspole I, Lartey S, Walters EH, Palmer AJ. Health-related quality of life of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis. Eur Respir Rev 2020;29:200154. [PMID: 33153990 DOI: 10.1183/16000617.0154-2020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
14 von Leupoldt A, Brighton LJ, Peters J, Volpato E, Verkleij M, Hutchinson A, Heijmans M, Farver-vestergaard I, Langer D, Spruit MA. ERS Scientific Working Group 09.04, “Psychologists and behavioural scientists”: the next step towards multidisciplinary respiratory care. Eur Respir J 2020;56:2001881. [DOI: 10.1183/13993003.01881-2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]